Drugs / Fibrin
Fibrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01253135 | Jan → Jul 2011 | — | Healthpoint | Completed | Missed primary |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01253135 ↗ |
| Known as | Factor 1a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108390 ↗ |
| Known as | Fibrina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108390 ↗ |
| Known as | Fibrine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108390 ↗ |
| Known as | Human fibrin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108390 ↗ |
| Modality | Protein / enzyme biologic | “Biological: Fibrin” NCT01253135 ↗ |
| Route | Topical | “Topical application of fibrinogen spray, followed by thrombin spray” NCT01253135 ↗ |